Surgery Partners, Inc. Cost of Revenue
Surgery Partners, Inc. (SGRY) reported Cost of Revenue of $388.00 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2020-03-13
- Surgery Partners, Inc. cost of revenue for the quarter ending 2019-12-31 was $388.00M, a 7.87% increase year-over-year.
- Surgery Partners, Inc. cost of revenue for the quarter ending 2019-09-30 was $353.10M, a 5.62% increase year-over-year.
- Surgery Partners, Inc. cost of revenue for the quarter ending 2019-06-30 was $340.40M, a 0.09% increase year-over-year.
- Surgery Partners, Inc. cost of revenue for the quarter ending 2019-03-31 was $326.10M, a 0.37% decline year-over-year.
- Surgery Partners, Inc. cost of revenue for fiscal 2019 was $1.41B, a 3.39% increase from fiscal 2018.
- Surgery Partners, Inc. cost of revenue for fiscal 2018 was $1.36B.
- Surgery Partners, Inc. cost of revenue for fiscal 2016 was $821.20M, a 22.69% increase from fiscal 2015.
- Surgery Partners, Inc. cost of revenue for fiscal 2015 was $669.33M, a 163.33% increase from fiscal 2014.
| Period end | Cost of Revenue 1 month | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 4 month | Cost of Revenue 4 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 8 month | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $388.00M 10-K · filed 2020-03-13 | $741.10M derived: sum of 2 quarters · filed 2020-03-13 | $1.08B derived: sum of 3 quarters · filed 2020-03-13 | $1.41B 10-K · filed 2020-03-13 | ||||||||
| 2019-09-30 | $353.10M 10-K · filed 2020-03-13 | $693.50M derived: sum of 2 quarters · filed 2020-03-13 | $1.02B 10-Q · filed 2019-11-06 | $1.38B derived: sum of 4 quarters · filed 2020-03-13 | ||||||||
| 2019-06-30 | $340.40M 10-K · filed 2020-03-13 | $666.50M 10-Q · filed 2019-08-09 | $1.03B derived: sum of 3 quarters · filed 2020-03-13 | $1.36B derived: sum of 4 quarters · filed 2020-03-13 | ||||||||
| 2019-03-31 | $326.10M 10-K · filed 2020-03-13 | $685.80M derived: sum of 2 quarters · filed 2020-03-13 | $1.02B derived: sum of 3 quarters · filed 2020-03-13 | $1.36B derived: sum of 4 quarters · filed 2020-03-13 | ||||||||
| 2018-12-31 | $359.70M 10-K · filed 2020-03-13 | $359.74M 10-K · filed 2019-03-15 | $694.00M derived: sum of 2 quarters · filed 2020-03-13 | $1.03B derived: sum of 3 quarters · filed 2020-03-13 | $1.36B 10-K · filed 2020-03-13 | $1.36B 10-K · filed 2019-03-15 | ||||||
| 2018-09-30 | $334.30M 10-K · filed 2020-03-13 | $334.29M 10-Q · filed 2018-11-09 | $674.40M derived: sum of 2 quarters · filed 2020-03-13 | $1.00B 10-Q · filed 2019-11-06 | $1.00B 10-Q · filed 2018-11-09 | $1.34B derived: sum of 4 quarters · filed 2020-03-13 | ||||||
| 2018-06-30 | $340.10M 10-K · filed 2020-03-13 | $340.09M 10-Q · filed 2018-08-09 | $667.40M 10-Q · filed 2019-08-09 | $667.40M 10-Q · filed 2018-08-09 | $1.01B derived: sum of 3 quarters · filed 2020-03-13 | |||||||
| 2018-03-31 | $327.30M 10-K · filed 2020-03-13 | $327.31M 10-Q · filed 2018-05-10 | $666.00M derived: sum of 2 quarters · filed 2020-03-13 | |||||||||
| 2017-12-31 | $338.70M 10-K · filed 2019-03-15 | $441.60M 10-K · filed 2020-03-13 | $441.63M 10-K · filed 2018-03-16 | |||||||||
| 2017-09-30 | $102.92M 10-K · filed 2019-03-15 | |||||||||||
| 2017-08-31 | $572.20M 10-K · filed 2020-03-13 | |||||||||||
| 2017-06-30 | $216.45M 10-Q · filed 2017-08-09 | $428.40M 10-Q · filed 2017-08-09 | $642.65M derived: sum of 3 quarters · filed 2017-08-09 | $844.04M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2017-03-31 | $211.95M 10-Q · filed 2017-05-10 | $426.19M derived: sum of 2 quarters · filed 2017-05-10 | $627.59M derived: sum of 3 quarters · filed 2017-05-10 | $836.44M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-12-31 | $214.25M 10-K · filed 2017-03-10 | $415.64M derived: sum of 2 quarters · filed 2017-03-10 | $624.49M derived: sum of 3 quarters · filed 2017-08-09 | $821.20M 10-K · filed 2017-03-10 | ||||||||
| 2016-09-30 | $201.39M 10-K · filed 2017-03-10 | $410.25M derived: sum of 2 quarters · filed 2017-08-09 | $606.95M 10-Q · filed 2016-11-10 | $790.12M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-06-30 | $208.85M 10-Q · filed 2017-08-09 | $405.56M 10-Q · filed 2017-08-09 | $588.73M derived: sum of 3 quarters · filed 2017-08-09 | $757.55M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||
| 2016-03-31 | $196.70M 10-Q · filed 2017-05-10 | $379.88M derived: sum of 2 quarters · filed 2017-05-10 | $548.70M derived: sum of 3 quarters · filed 2017-05-10 | $710.26M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||
| 2015-12-31 | $183.17M 10-K · filed 2017-03-10 | $352.00M derived: sum of 2 quarters · filed 2017-03-10 | $513.55M derived: sum of 3 quarters · filed 2017-03-10 | $669.33M 10-K · filed 2017-03-10 | ||||||||
| 2015-09-30 | $168.82M 10-K · filed 2017-03-10 | $330.38M derived: sum of 2 quarters · filed 2017-03-10 | $486.15M 10-Q · filed 2016-11-10 | $606.74M derived: sum of 4 quarters · filed 2017-03-10 | ||||||||
| 2015-06-30 | $161.56M 10-K · filed 2017-03-10 | $317.33M 10-Q · filed 2016-08-10 | $437.92M derived: sum of 3 quarters · filed 2017-03-10 | $483.30M derived: sum of 4 quarters · filed 2017-03-10 | ||||||||
| 2015-03-31 | $155.77M 10-K · filed 2017-03-10 | $276.36M derived: sum of 2 quarters · filed 2017-03-10 | $321.74M derived: sum of 3 quarters · filed 2017-03-10 | $366.90M derived: sum of 4 quarters · filed 2017-03-10 | ||||||||
| 2014-12-31 | $120.59M 10-K · filed 2016-03-11 | $165.96M derived: sum of 2 quarters · filed 2016-03-11 | $211.13M derived: sum of 3 quarters · filed 2016-03-11 | $254.18M 10-K · filed 2017-03-10 | ||||||||
| 2014-09-30 | $45.38M 10-K · filed 2016-03-11 | $90.54M derived: sum of 2 quarters · filed 2016-03-11 | $133.59M 10-Q · filed 2015-11-13 | |||||||||
| 2014-06-30 | $45.16M 10-K · filed 2016-03-11 | $88.21M derived: sum of 2 quarters · filed 2016-03-11 | ||||||||||
| 2014-03-31 | $43.05M 10-K · filed 2016-03-11 | |||||||||||
| 2013-12-31 | $169.84M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |